Balanced news tone
News Sentiment
ORCHPHARMA sentiment intelligence
Orchid Pharma Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
77/100 classification confidence.
directly relevant articles
high-authority source matches
+5.9% over one week, +10.4% over four weeks, trend active, and near fair-value range.
Orchid Pharma Completes Dhanuka Laboratories Merger, Ups Authorised Capital
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Orchid Pharma Completes Dhanuka Laboratories Merger, Ups Authorised Capital
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 10 Jul 2026 16:08
- Source
- TipRanks
Orchid Pharma Finalizes Merger with Dhanuka, Boosts Authorised Capital and Sets Record Date
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 10 Jul 2026 15:58
- Source
- TipRanks
Orchid Pharma Shares Zooms 10% On Russian Market Entry With Antibiotic Licensing Deal
- Tone
- Positive 58/100
- Event
- Deals and strategy
- Published
- 08 Jul 2026 07:06
- Source
- NDTV Profit
Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 07:01
- Source
- Business Standard
Orchid Pharma Shares Jump 12% on $178 Mn Russia Deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 08 Jul 2026 05:51
- Source
- Equitypandit
Triple-Digit PE Pharma Stock Jumps 10% as Company Signs Russia Licensing Deal; Share Price Crosses Rs 1,000
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 08 Jul 2026 04:51
- Source
- Dalal Street Investment Journal
Stocks to Watch Today: Orchid Pharma, HCL Tech, EMS, Silver Touch, Knack Packaging, Ganesh Infraworld,...
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 19:30
- Source
- Moneycontrol.com
NCLT sanctions Orchid Pharma-Dhanuka Labs merger
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 12 Jun 2026 07:00
- Source
- scanx.trade
Some May Be Optimistic About Orchid Pharma's (NSE:ORCHPHARMA) Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 Jun 2026 07:00
- Source
- simplywall.st
Sun Pharma to Dr. Reddy's: Healthcare Stocks to Watch Ahead of Q4 Results, Cipla Among Systematix Top Picks
- Tone
- Positive 58/100
- Event
- Earnings
- Published
- 15 Apr 2026 07:00
- Source
- NDTV Profit
Orchid Pharma Limited Schedules Investor Roadshow for April 10, 2026 in Gurugram
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Apr 2026 07:00
- Source
- scanx.trade
Orchid Pharma Finalizes Acquisition of Allecra Therapeutics Assets
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 30 Oct 2025 07:00
- Source
- scanx.trade
Orchid Pharma Limited's (NSE:ORCHPHARMA) Stock Is Going Strong: Have Financials A Role To Play?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Sep 2025 07:00
- Source
- simplywall.st
Some Orchid Pharma Limited (NSE:ORCHPHARMA) Analysts Just Made A Major Cut To Next Year's Estimates
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 18 Aug 2025 07:00
- Source
- simplywall.st
Orchid Pharma gets formal nod from Court of France for Allecra Therapeutics acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 08 Aug 2025 07:00
- Source
- Business Standard
There's Reason For Concern Over Orchid Pharma Limited's (NSE:ORCHPHARMA) Price
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 05 Aug 2025 07:00
- Source
- simplywall.st
Orchid Pharma Hits Upper Circuit on Buyback of Novel Antibiotic Rights
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 31 Jul 2025 07:00
- Source
- Equitypandit
Orchid Pharma Shares Surge as Company Reclaims Global Rights to Novel Antibiotic
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Jul 2025 07:00
- Source
- scanx.trade
Orchid Pharma share price hits 5% upper circuit; stock jumps 24% in 1 week
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Feb 2025 08:00
- Source
- Upstox
Orchid Pharma shares in focus as U.S. FDA completes facility inspection
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Feb 2025 08:00
- Source
- The Economic Times
Orchid Pharma rises 4% on deal with Cipla to roll out new UTI drug in India
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 01 Jul 2024 07:00
- Source
- Business Standard
Orchid Pharma shares hit 52-week high on raising ₹400 cr via QIP
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2023 07:00
- Source
- Fortune India
ORCHID PHARMA Share Price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jan 2022 10:37
- Source
- Upstox
Orchid Pharma | Stock Share Price Live
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Oct 2021 12:30
- Source
- MarketSmith India